Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCC1806 | ZSTK474 | 1 | 72 | 0.0032 | 11595.8 | 11395.8 | 1742.8 | -2.49 | 1.010 | 1.020 | 2.709 | HCC1806 ZSTK474 0 1 72 |
| HCC1806 | ZSTK474 | 1 | 72 | 0.01 | 11648.8 | 11395.8 | 1742.8 | -2.0 | 1.020 | 1.020 | 2.709 | HCC1806 ZSTK474 0 1 72 |
| HCC1806 | ZSTK474 | 1 | 72 | 0.032 | 11901.8 | 11395.8 | 1742.8 | -1.49 | 1.030 | 1.040 | 2.709 | HCC1806 ZSTK474 0 1 72 |
| HCC1806 | ZSTK474 | 1 | 72 | 0.1 | 11540.8 | 11395.8 | 1742.8 | -1.0 | 1.010 | 1.010 | 2.709 | HCC1806 ZSTK474 0 1 72 |
| HCC1806 | ZSTK474 | 1 | 72 | 0.32 | 11381.0 | 11395.8 | 1742.8 | -0.495 | 0.999 | 0.999 | 2.709 | HCC1806 ZSTK474 0 1 72 |
| HCC1806 | ZSTK474 | 1 | 72 | 1.0 | 9516.5 | 11395.8 | 1742.8 | 0.0 | 0.871 | 0.835 | 2.709 | HCC1806 ZSTK474 0 1 72 |